Dillard's (DDS)
(Delayed Data from NYSE)
$370.07 USD
-1.45 (-0.39%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $370.52 +0.45 (0.12%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$370.07 USD
-1.45 (-0.39%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $370.52 +0.45 (0.12%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Zacks News
Dillard's (DDS) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Dillard's (DDS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Dillard's (DDS) delivered earnings and revenue surprises of 125.05% and 3.61%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNX
Dillard's (DDS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Dillard's (DDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNY
What to Expect from Dillard's (DDS) Q3 Earnings
by Shaun Pruitt
Dillard's (DDS) third quarter earnings on November 9 will be significant and insightful into the effects an economic downturn is having on the economy. Earnings estimate revisions trending higher is a good sign that the company may beat earnings expectations again.
Factors Likely to Influence Dillard's (DDS) in Q3 Earnings
by Zacks Equity Research
Dillard's (DDS) Q3 results are expected to reflect gains from strong demand trends and efficient inventory management amid rising SG&A expenses and supply-chain costs.
Is First Trust Mid Cap Core AlphaDEX ETF (FNX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNX
Dillard's (DDS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $328.79, moving +1.13% from the previous trading session.
Are Retail-Wholesale Stocks Lagging Dillard's (DDS) This Year?
by Zacks Equity Research
Here is how Dillard's (DDS) and Kroger (KR) have performed compared to their sector so far this year.
Here's How Much a $1000 Investment in Dillard's Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Dillard's (DDS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $322.21 in the latest trading session, marking a +0.72% move from the prior day.
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Dillard's (DDS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $298.32 in the latest trading session, marking a -1.51% move from the prior day.
Dillard's (DDS) Stock Moves -0.55%: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $280.87, moving -0.55% from the previous trading session.
Kohl's (KSS) Slumps More Than 55% in 6 Months: Here's Why
by Zacks Equity Research
Kohl's (KSS) is battling a tough macroeconomic landscape, increased inflation and sluggish consumer spending. Rising SG&A expenses are a concern.
Here's Why DICK'S Sporting (DKS) Looks Poised for Growth
by Zacks Equity Research
DICK'S Sporting (DKS) remains well-placed for long-term growth on the back of robust consumer demand, a solid product portfolio and strength in stores.
Costco (COST) Rides on Business Model and Pricing Power
by Zacks Equity Research
A customer-centric approach, strategic pricing, merchandise initiatives and an emphasis on memberships help Costco (COST) post consistent sales growth.
Dillard's (DDS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Dillard's (DDS) closed at $282.88, marking a +0.58% move from the previous day.
Are Retail-Wholesale Stocks Lagging Dillard's (DDS) This Year?
by Zacks Equity Research
Here is how Dillard's (DDS) and Performance Food Group (PFGC) have performed compared to their sector so far this year.
Dillard's and JELD-WEN have been highlighted as Zacks Bull and Bear of the Day
by Santanu Roy
Dillard's and JELD-WEN are part of Zacks Bull and Bear of the Day article.
Bull of the Day: Dillard's, Inc. (DDS)
by Bryan Hayes
Stocks that are able to show resilience during bear markets tend to lead the upside once the market turns the corner.
Ollie's Bargain (OLLI) Business Model, Loyalty Program Bode Well
by Zacks Equity Research
Although Ollie's Bargain (OLLI) faces supply chain headwinds, we believe improved closeout opportunities and room for store growth should support the stock.
Bed Bath & Beyond (BBBY) Q2 Loss Widens, Sales Lag Estimates
by Zacks Equity Research
Bed Bath & Beyond's (BBBY) Q2 results have been hurt by drab demand, reduced consumer spending and supply-chain issues. It expects to turn around in the near term.
5 Stocks With High ROE to Buy as Markets Regain Momentum
by Supriyo Bose
AES Corporation (AES), PepsiCo (PEP), Dillard's (DDS), Suzano (SUZ) and Arch Capital (ACGL) are some of the stocks with high ROE to profit from as markets appear to regain lost ground.